Corticotropin-releasing factor and interleukin-1beta are involved in the electroacupuncture-induced analgesic effect on inflammatory pain elicited by carrageenan.
Electroacupuncture (EA) is used to relieve various kinds of pain. However, the mechanistic basis of electroacupuncture analgesia (EAA) in inflammatory pain remains unclear. In the present study, we investigated whether endogenous peripheral corticotropin-releasing factor (CRF) or interleukin-1beta (IL-1) participated in EAA during hyperalgesia elicited by carrageenan-induced inflammation. Carrageenan was subcutaneously administered by intraplantar (i.pl.) injection of the left hind paw to induce inflammation. Nociceptive thresholds were measured using the paw pressure threshold (PPT) (Randall Sellito Test). Rats received 3 Hz EA in the left anterior tibial muscles for 1 hour after carrageenan injection. The selective CRF antagonist, alpha-helical CRF, or the recombinant IL-1 receptor antagonist, IL-1ra, was administered by i.pl. injection of the inflamed paw or by intravenous (i.v.) injection 1 hour before EA. PPT decreased significantly 3 hours after carrageenan injection. This decrease persisted at least 24 hours after carrageenan injection. EA resulted in significant increases of PPT, moreover, PPT elevations lasted 24 hours after carrageenan injection. By contrast, PPT elevations produced by EA were dose-dependently antagonized by local i.pl. injection of alpha-helical CRF or IL-1ra. This PPT elevation was not influenced by i.v. injection of alpha-helical CRF or IL-1ra. These findings suggest that peripheral CRF or IL-1 participate in EAA during hyperalgesia. The release of CRF or IL-1 elicited by EA may trigger the release of opioid peptides within inflamed tissue which may activate peripheral opioid receptors and inhibit the pain.
Sekido
Reina
R
Department of Surgery, Graduate School of Acupuncture and Moxibustion, Meiji University of Oriental Medicine, Kyoto, Japan. r_sekido@muom.meiji-u.ac.jp
Ishimaru
Keisou
K
Sakita
Masakazu
M
D000698:Analgesia; D000818:Animals; D002351:Carrageenan / Q000494:pharmacology*; D003346:Corticotropin-Releasing Hormone / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D015671:Electroacupuncture; D007249:Inflammation / Q000150:complications; D007279:Injections, Subcutaneous; D007375:Interleukin-1 / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D010146:Pain / Q000503:physiopathology*; D059408:Pain Management; D051381:Rats; D017207:Rats, Sprague-Dawley
D007375:Interleukin-1; D002351:Carrageenan; D003346:Corticotropin-Releasing Hormone